Differential microRNA expression in the peripheral blood from human patients with COVID-19

Caixia Li, Xiao Hu, Leilei Li, Jin-Hui Li, Caixia Li, Xiao Hu, Leilei Li, Jin-Hui Li

Abstract

Introduction: The coronavirus disease (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which play important roles in regulating gene expression and are also considered as essential modulators during viral infection. The aim of this study was to elucidate the differential expression of miRNAs in COVID-19.

Methods: The total RNA was extracted and purified from the peripheral blood of ten patients with COVID-19 and four healthy donors. The expression levels of various miRNAs were detected by high-throughput sequencing, and correlation analysis was performed on the target genes that are primed by miRNAs.

Key findings: Compared with the healthy controls, 35 miRNAs were upregulated and 38 miRNAs were downregulated in the human patients with COVID-19. The top 10 genes were listed below: hsa-miR-16-2-3P,hsa-miR-5695,hsa-miR-10399-3P,hsa-miR-6501-5P,hsa-miR-361-3P,hsa-miR-361-3p, hsa-miR-4659a-3p, hsa-miR-142-5p, hsa-miR-4685-3p, hsa-miR-454-5p, and hsa-miR-30c-5p. The 10 genes with the greatest reduction were listed below: hsa-miR-183-5p, hsa-miR-627-5p, hsa-miR-941, hsa-miR-21-5p, hsa-miR-20a-5p, hsa-miR-146b-5p, hsa-miR-454-3p, hsa-miR-18a-5p, hsa-miR-340-5p, and hsa-miR-17-5p. Remarkably, miR-16-2-3p was the most upregulated miRNA, with a 1.6-fold change compared to that of the controls. Moreover, the expression of miR-6501-5p and miR-618 was 1.5-fold higher in the COVID-19 patients than in the healthy donors. Meanwhile, miR-627-5p was the most downregulated miRNA, with a 2.3-fold change compared to that of the controls. The expression of other miRNAs (miR-183-5p, miR-627-5p, and miR-144-3p) was reduced by more than 1.3-fold compared to that of the healthy donors. Cluster analysis revealed that all of the differentially expressed miRNA target genes were clustered by their regulation of cellular components, molecular functions, and biological processes. Importantly, peptidases, protein kinases, and the ubiquitin system were shown to be the highest enrichment categories by enrichment analysis.

Conclusions: The differential miRNA expression found in COVID-19 patients may regulate the immune responses and viral replication during viral infection.

Keywords: Bioinformatics analysis; COVID-19; high-throughput sequencing; microRNA.

© 2020 The Authors. Journal of Clinical Laboratory Analysis Published by Wiley Periodicals LLC.

Figures

Figure 1
Figure 1
Differential miRNA expression between COVID‐19 patients and healthy donors. Each point in the figure represents a gene, and the abscissa represents the logarithmic value logFC of the multiple differences of gene expression between the two groups. The ordinate represents the negative pair value of the p‐value of the change in gene expression. The greater the absolute value of the abscissa, the greater the difference of expression between the two groups. The larger the ordinate value, the more significant the difference in expression. Genes with significant differences are represented by red and blue dots, and genes without significant differences are represented by green dots
Figure 2
Figure 2
Differential miRNA expression between COVID‐19 patients and healthy donors. Genes with significant differences are represented by red and blue dots, and genes without significant differences are represented by green dots
Figure 3
Figure 3
Differential gene expression between COVID‐19 patients and healthy donors. Each column represents a different sample. Lines represent different genes. The color represents the level of gene expression in the sample. Red indicates a high gene expression in the sample, and blue indicates a low gene expression in the sample
Figure 4
Figure 4
The GO classification of differentially expressed genes between the COVID‐19 patients and the control group
Figure 5
Figure 5
KEGG enrichment analysis of the differentially expressed genes

References

    1. The L. Emerging understandings of 2019‐nCoV. Lancet. 2020;395:311.
    1. Rubin EJ, Baden LR, Morrissey S, Campion EW. Medical Journals and the 2019‐nCoV Outbreak. N Engl J Med. 2020;382:866.
    1. Nkengasong J. China's response to a novel coronavirus stands in stark contrast to the 2002 SARS outbreak response. Nat Med. 202026(3):310–311.
    1. Moore JB, June CH. Cytokine release syndrome in severe COVID‐19. Science. 2020;368:473–474.
    1. Rothe Camilla, Schunk Mirjam, Sothmann Peter, et al. Transmission of 2019‐nCoV Infection from an Asymptomatic Contact in Germany. N Engl J Med. 2020;382:970–971.
    1. Holshue ML, DeBolt C, Lindquist S, et al. First Case of 2019 Novel Coronavirus in the United States. N Engl J Med. 2020;382(10):929‐936.
    1. Phan Lan T, Nguyen Thuong V, Luong Quang C, et al. Importation and Human‐to‐Human Transmission of a Novel Coronavirus in Vietnam. N Engl J Med. 2020;382(9):872–874.
    1. Chan Jasper Fuk‐Woo, Kok Kin‐Hang, Zhu Zheng, et al. Genomic characterization of the 2019 novel human‐pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect. 2020;9:221–236.
    1. Yin C. Genotyping coronavirus SARS‐CoV‐2: methods and implications. Genomics. 2020;112(5):3588–3596.
    1. Fu X, Liu P, Dimopoulos G, Zhu J. Dynamic miRNA‐mRNA interactions coordinate gene expression in adult Anopheles gambiae. PLoS Genet. 2020;16:e1008765.
    1. Hua Mingqiang, Li Ju, Wang Chunyan, Shao Linlin, et al. Aberrant expression of microRNA in CD4(+) cells contributes to Th17/Treg imbalance in primary immune thrombocytopenia. Thromb Res. 2019;177:70–78.
    1. Rossato Marzia, Affandi Alsya J, Thordardottir Soley, et al. Association of MicroRNA‐618 Expression With Altered Frequency and Activation of Plasmacytoid Dendritic Cells in Patients With Systemic Sclerosis. Arthritis Rheumatol. 2017;69:1891–1902.
    1. Li W, He C, Wu J, Yang D, Yi W. Epstein barr virus encodes miRNAs to assist host immune escape. J Cancer. 2020;11:2091–2100.
    1. Bandopadhyay M, Bharadwaj M. Exosomal miRNAs in hepatitis B virus related liver disease: a new hope for biomarker. Gut Pathog. 2020;12:23.
    1. Zhao Qing, Xiong Yuan, Xu Jingru, Chen Shuang, Li Pu, Huang Yong, Wang Yunying, Chen Wei‐Xian, Wang Bo. Host MicroRNA hsa‐miR‐494‐3p Promotes EV71 Replication by Directly Targeting PTEN. Front Cell Infect Microbiol. 2018;8:278.
    1. Canatan D, De Sanctis V. The impact of MicroRNAs (miRNAs) on the genotype of coronaviruses. Acta Biomed. 2020;91:195–198.
    1. Russell CD, Millar JE, Baillie JK. Clinical evidence does not support corticosteroid treatment for 2019‐nCoV lung injury. Lancet. 2020;395:473–475.
    1. Wang WW, Yang L, Wu J, et al. The function of miR‐218 and miR‐618 in postmenopausal osteoporosis. Eur Rev Med Pharmacol Sci. 2017;21:5534–5541.
    1. Santos‐Bezerra Daniele P, Santos Aritania S, Guimarães Gabriel C, et al. Micro‐RNAs 518d–3p and 618 Are Upregulated in Individuals With Type 1 Diabetes With Multiple Microvascular Complications. Front Endocrinol (Lausanne). 2019;10:385.
    1. Li B, Zhao J, Zhao Q, et al. MicroRNA‐618 Directly Targets Metadherin mRNA To Suppress The Malignant Phenotype Of Osteosarcoma Cells By Reducing PTEN‐AKT Pathway Output. Onco Targets Ther. 2019;12:9795–9807.

Source: PubMed

3
Iratkozz fel